Labcorp said revenue for Q1 2025 (as of March 31) rose to $3.35 billion, up 5.3% from $3.18 billion a year earlier, and diluted EPS was $2.52 compared with $2.69 a year earlier.

1. 01

   Labcorp said revenue for Q1 2025 (as of March 31) rose to $3.35 billion, up 5.3% from $3.18 billion a year earlier, and diluted EPS was $2.52 compared with $2.69 a year earlier.

2. 02

   The company said adjusted operating income (non-GAAP) for Q1 was $469.0 million, compared with $452.8 million a year earlier, adjusted operating margin was 14.0% versus 14.3% a year earlier, and adjusted EPS was $3.84 compared with $3.68 a year earlier.

3. 03

   Labcorp said operating cash flow for Q1 was $18.5 million (compared with $(29.8) million a year earlier), free cash flow was $(107.5) million, and cash and cash equivalents at quarter-end were $0.37 billion and total debt was $5.57 billion.

4. 04

   Labcorp said it maintained its 2025 full-year revenue guidance of 6.7% to 8.0% and free cash flow guidance of $1.10 billion to $1.25 billion, and it provided an adjusted EPS range of $15.70 to $16.40, raising the midpoint by $0.05. The previous adjusted EPS guidance was $15.60 to $16.40.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.